Bigfoot Biomedical CEO hits back against CMS over data-sharing decision

This article was originally published here

Bigfoot BiomedicalBigfoot Biomedical CEO Jeffrey Brewer has spoken out about a recent data-sharing decision made by CMS, saying that he plans to lobby Medicare to reverse its latest move.

Earlier this year, CMS said it would begin covering the use of particular continuous glucose monitors for people with diabetes. But since that decision, the agency has said that if a beneficiary uses a non-durable medical equipment device, like a smartphone, separately or in combination with a device classified as DME, it will not be reimbursed.

In other words, according to Brewer, Medicare will not reimburse for ‘s (NSDQ:DXCM) G5 smartphone app. The chief executive said that people who use Dexcom’s glucose monitor have reported that they can’t use the company’s share function that allows a family member or another person to remotely monitor the user’s glucose levels.

Get the full story at our sister site, Drug Delivery Business News.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply